Shared on 30 Jul 25
Fair value Decreased 65%The sharp reduction in ModivCare's analyst price target from $5.57 to $1.98 is primarily driven by weaker revenue growth forecasts and a lower future P/E multiple, reflecting deteriorating growth and valuation sentiment. What's in the News ModivCare Inc.
Shared on 01 May 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 9.00%AnalystConsensusTarget has decreased revenue growth from 1.6% to 1.2% and increased future PE multiple from 0.7x to 0.9x.
Shared on 09 Apr 25
Fair value Increased 6.83%AnalystConsensusTarget has increased revenue growth from 0.9% to 1.6% and increased shares outstanding growth rate from 0.0% to 0.0%.